Lobato M Natividad, Rabbitts Terence H
MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK.
Trends Mol Med. 2003 Sep;9(9):390-6. doi: 10.1016/s1471-4914(03)00163-1.
A key feature of antibodies is their ability to bind antigens with high specificity and affinity. This has led to the concept of intracellular antibodies (intrabodies), designed to mimic antibody-antigen binding, but inside cells. Antibody fragments comprising the antigen-binding variable domains are convenient formats for intrabodies, potentially allowing for intracellular functionality. Intrabodies are promising tools, capable of interfering with a wide range of molecular targets in various intracellular compartments. However, many significant challenges remain to be overcome before intrabodies can be useful therapeutic agents. Although major progress has been made in the design and selection of intrabodies, new developments and advances are needed to allow their efficient delivery and expression for treatment of human diseases.
抗体的一个关键特性是它们能够以高特异性和亲和力结合抗原。这催生了细胞内抗体(intrabodies)的概念,其旨在模拟抗体 - 抗原结合,但在细胞内部进行。包含抗原结合可变域的抗体片段是细胞内抗体的便利形式,可能具备细胞内功能。细胞内抗体是很有前景的工具,能够干扰各种细胞内区室中的广泛分子靶点。然而,在细胞内抗体成为有用的治疗药物之前,仍有许多重大挑战有待克服。尽管在细胞内抗体的设计和筛选方面已取得重大进展,但仍需要新的发展和进步,以实现其有效递送和表达,用于治疗人类疾病。